Systematic review of preservation solutions for allografts for liver transplantation based on a network meta-analysis

Int J Surg. 2018 Jun;54(Pt A):1-6. doi: 10.1016/j.ijsu.2018.04.024. Epub 2018 Apr 21.

Abstract

Aims: The aim of this work was to determine the best preservation solutions for allografts for liver transplantation by quantitative network meta-analysis.

Methods: Global electronic databases including PubMed, EMBASE, and Cochrane Library were searched for relevant randomized controlled trials. Seven pieces of parametric data were extracted from included studies for pooled estimation. A consistency model was used for direct and indirect comparisons. The cumulative probability P value was utilized to rank the solutions. A node-splitting model was utilized for testing the consistency of final data. Quality of evidence was assessed using the GRADE (Grades of Recommendations Assessment, Development and Evaluation) system.

Results: Eleven 2-arm trials including 1319 patients and 5 different solutions were finally included. HTK (Histidine-tryptophan-ketoglutarate) solution exhibited the best efficacy for decreasing the primary dysfunction rate, biliary complications and ICU-stay time (probability P = 0.43, 0.45 and 0.58, respectively). Celsior solution significantly decreased the rate of rejection and early retransplantation (probability P = 0.73 and 0.38, respectively), and enhanced patient and graft survival (probability P = 0.90 and 0.98, respectively) more than did other solutions. Overall, the quality of evidence was rated high or moderate.

Conclusions: We suggested that HTK solution may offer the best safety during the perioperative period. However, Celsior solution led to better graft tolerance and exhibited greater benefit for long-term outcomes. And our conclusions still need to be further validated.

Keywords: Liver transplantation; Network meta-analysis; Preservation solutions.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Allografts*
  • Disaccharides / therapeutic use
  • Electrolytes / therapeutic use
  • Glucose / standards
  • Glutamates / therapeutic use
  • Glutathione / therapeutic use
  • Graft Survival / drug effects*
  • Histidine / therapeutic use
  • Humans
  • Liver Transplantation
  • Liver*
  • Mannitol / standards
  • Mannitol / therapeutic use
  • Network Meta-Analysis
  • Organ Preservation / methods
  • Organ Preservation Solutions / standards*
  • Potassium Chloride / standards
  • Procaine / standards

Substances

  • Bretschneider cardioplegic solution
  • Celsior
  • Disaccharides
  • Electrolytes
  • Glutamates
  • Organ Preservation Solutions
  • Mannitol
  • Histidine
  • Procaine
  • Potassium Chloride
  • Glutathione
  • Glucose